Overview

Double-Blind Naltrexone in Kleptomania

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in kleptomania.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Treatments:
Naltrexone